These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23315227)

  • 1. [Pneumococcal infections -- clinical features, prevention and current therapy. Interview with Dr. Endre Ludwig by Anna Radnai].
    Ludwig E
    Orv Hetil; 2013 Jan; 154(3):118-20. PubMed ID: 23315227
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
    Aguilar L; Giménez MJ
    Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
    [No Abstract]   [Full Text] [Related]  

  • 4. [Incidence and diagnosis of invasive pneumococcal disease].
    Jørgensen MA; Deutch S; Møller BK; Østergaard LJ
    Ugeskr Laeger; 2004 May; 166(22):2133-7. PubMed ID: 15222163
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
    Weiser JN; Austrian R
    Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset Streptococcus pneumoniae neonatal sepsis and meningitis in the 13-valent vaccine era.
    Fothy JF; Vetter S; Iñigo A; Gil J; Pérez JL; Hervás JA
    Pediatr Infect Dis J; 2013 Nov; 32(11):1299-300. PubMed ID: 24141804
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An update of Streptococcus pneumoniae: from genomic to clinic].
    Wintenberger C
    Med Mal Infect; 2010 Oct; 40(10):605-9. PubMed ID: 20934286
    [No Abstract]   [Full Text] [Related]  

  • 10. Pneumococcal resistance in perspective: how well are we combating it?
    Amsden GW
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S125-8. PubMed ID: 14770075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumococcal infection in adults: the needs not satisfied].
    Bonanni P
    Ig Sanita Pubbl; 2011; 67(4):489-510. PubMed ID: 22033206
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
    Okade H; Funatsu T; Eto M; Furuya Y; Mizunaga S; Nomura N; Mitsuyama J; Yamagishi Y; Mikamo H
    J Infect Chemother; 2014 Jul; 20(7):423-8. PubMed ID: 24802765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thousand faces of Streptococcus pneumonia (pneumococcus) infections].
    Szabó BG; Lénárt KS; Kádár B; Gombos A; Dezsényi B; Szanka J; Bobek I; Prinz G
    Orv Hetil; 2015 Nov; 156(44):1769-77. PubMed ID: 26498896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and phenotypic characterisation of invasive Streptococcus pneumoniae isolates from Hungary, and coverage of the conjugate vaccines.
    Dobay O; Ungvári A; Kardos S; Kristóf K; Hajdú E; Szabó J; Knausz M; Nagy E; Rozgonyi F; Amyes SG; Nagy K
    J Clin Pathol; 2010 Dec; 63(12):1116-20. PubMed ID: 20943819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
    Nuermberger EL; Bishai WR
    Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical impact of resistance in the management of pneumococcal disease.
    Leggiadro RJ
    Infect Dis Clin North Am; 1997 Dec; 11(4):867-74. PubMed ID: 9421704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing focus on local epidemiology demonstrates potential value of pneumococcal conjugate vaccines in Middle East and North Africa Region.
    Pelton SI
    Vaccine; 2012 Dec; 30 Suppl 6():G1. PubMed ID: 23228351
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
    Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance and the potential impact of pneumococcal conjugate vaccines.
    Dagan R
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S134-42. PubMed ID: 12807290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Stein M; Megged O; Bar-Yochai A; Negari S; Dagan R;
    Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.